vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Tenable Holdings, Inc. (TENB). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $262.1M, roughly 2.9× Tenable Holdings, Inc.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs 0.5%, a 3.1% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 9.6%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 8.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Tenable Holdings, Inc. is a cybersecurity company based in Columbia, Maryland. Its vulnerability scanner software Nessus, developed in 1998, is one of the most widely deployed vulnerability assessment solutions in the cybersecurity industry. As of December 31, 2023, the company had approximately 44,000 customers, including 65% of the Fortune 500.

CLOV vs TENB — Head-to-Head

Bigger by revenue
CLOV
CLOV
2.9× larger
CLOV
$749.2M
$262.1M
TENB
Growing faster (revenue YoY)
CLOV
CLOV
+52.5% gap
CLOV
62.0%
9.6%
TENB
Higher net margin
CLOV
CLOV
3.1% more per $
CLOV
3.6%
0.5%
TENB
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
8.8%
TENB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLOV
CLOV
TENB
TENB
Revenue
$749.2M
$262.1M
Net Profit
$27.3M
$1.4M
Gross Margin
78.4%
Operating Margin
3.6%
25.0%
Net Margin
3.6%
0.5%
Revenue YoY
62.0%
9.6%
Net Profit YoY
EPS (diluted)
$0.05
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TENB
TENB
Q1 26
$749.2M
$262.1M
Q4 25
$487.7M
$260.5M
Q3 25
$496.6M
$252.4M
Q2 25
$477.6M
$247.3M
Q1 25
$462.3M
$239.1M
Q4 24
$337.0M
$235.7M
Q3 24
$331.0M
$227.1M
Q2 24
$356.3M
$221.2M
Net Profit
CLOV
CLOV
TENB
TENB
Q1 26
$27.3M
$1.4M
Q4 25
$-49.3M
$-737.0K
Q3 25
$-24.4M
$2.3M
Q2 25
$-10.6M
$-14.7M
Q1 25
$-1.3M
$-22.9M
Q4 24
$-22.1M
$1.9M
Q3 24
$-9.2M
$-9.2M
Q2 24
$7.4M
$-14.6M
Gross Margin
CLOV
CLOV
TENB
TENB
Q1 26
78.4%
Q4 25
78.8%
Q3 25
77.5%
Q2 25
78.0%
Q1 25
78.1%
Q4 24
78.2%
Q3 24
24.5%
77.8%
Q2 24
30.3%
77.9%
Operating Margin
CLOV
CLOV
TENB
TENB
Q1 26
3.6%
25.0%
Q4 25
-10.1%
3.4%
Q3 25
-4.9%
2.8%
Q2 25
-2.2%
-3.0%
Q1 25
-0.3%
-7.4%
Q4 24
-6.4%
5.5%
Q3 24
-2.7%
-0.9%
Q2 24
2.0%
-4.0%
Net Margin
CLOV
CLOV
TENB
TENB
Q1 26
3.6%
0.5%
Q4 25
-10.1%
-0.3%
Q3 25
-4.9%
0.9%
Q2 25
-2.2%
-5.9%
Q1 25
-0.3%
-9.6%
Q4 24
-6.6%
0.8%
Q3 24
-2.8%
-4.1%
Q2 24
2.1%
-6.6%
EPS (diluted)
CLOV
CLOV
TENB
TENB
Q1 26
$0.05
$0.01
Q4 25
$-0.01
Q3 25
$0.02
Q2 25
$-0.12
Q1 25
$-0.19
Q4 24
$0.01
Q3 24
$-0.08
Q2 24
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TENB
TENB
Cash + ST InvestmentsLiquidity on hand
$177.6M
$360.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
$248.2M
Total Assets
$697.7M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TENB
TENB
Q1 26
$177.6M
$360.3M
Q4 25
$78.3M
$402.2M
Q3 25
$383.6M
Q2 25
$386.5M
Q1 25
$460.3M
Q4 24
$194.5M
$577.2M
Q3 24
$288.0M
$548.4M
Q2 24
$254.8M
$487.0M
Stockholders' Equity
CLOV
CLOV
TENB
TENB
Q1 26
$339.4M
$248.2M
Q4 25
$308.7M
$326.4M
Q3 25
$340.9M
$344.4M
Q2 25
$344.2M
$350.7M
Q1 25
$336.1M
$383.2M
Q4 24
$341.1M
$400.0M
Q3 24
$342.2M
$404.6M
Q2 24
$324.9M
$363.6M
Total Assets
CLOV
CLOV
TENB
TENB
Q1 26
$697.7M
$1.6B
Q4 25
$541.0M
$1.7B
Q3 25
$559.7M
$1.7B
Q2 25
$575.0M
$1.7B
Q1 25
$583.7M
$1.7B
Q4 24
$580.7M
$1.7B
Q3 24
$653.0M
$1.6B
Q2 24
$674.2M
$1.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
TENB
TENB
Operating Cash FlowLast quarter
$88.0M
Free Cash FlowOCF − Capex
$82.6M
FCF MarginFCF / Revenue
31.5%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
62.21×
TTM Free Cash FlowTrailing 4 quarters
$256.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
TENB
TENB
Q1 26
$88.0M
Q4 25
$-66.9M
$83.0M
Q3 25
$12.1M
$53.9M
Q2 25
$5.4M
$42.5M
Q1 25
$-16.3M
$87.4M
Q4 24
$34.8M
$81.1M
Q3 24
$50.0M
$54.6M
Q2 24
$44.8M
$31.4M
Free Cash Flow
CLOV
CLOV
TENB
TENB
Q1 26
$82.6M
Q4 25
$-69.0M
$82.7M
Q3 25
$11.4M
$53.0M
Q2 25
$4.8M
$38.1M
Q1 25
$-16.5M
$80.9M
Q4 24
$33.3M
$78.8M
Q3 24
$49.6M
$53.9M
Q2 24
$44.4M
$30.9M
FCF Margin
CLOV
CLOV
TENB
TENB
Q1 26
31.5%
Q4 25
-14.1%
31.7%
Q3 25
2.3%
21.0%
Q2 25
1.0%
15.4%
Q1 25
-3.6%
33.8%
Q4 24
9.9%
33.4%
Q3 24
15.0%
23.7%
Q2 24
12.5%
14.0%
Capex Intensity
CLOV
CLOV
TENB
TENB
Q1 26
Q4 25
0.4%
0.1%
Q3 25
0.1%
0.3%
Q2 25
0.1%
1.8%
Q1 25
0.0%
2.7%
Q4 24
0.5%
1.0%
Q3 24
0.1%
0.3%
Q2 24
0.1%
0.2%
Cash Conversion
CLOV
CLOV
TENB
TENB
Q1 26
62.21×
Q4 25
Q3 25
23.83×
Q2 25
Q1 25
Q4 24
43.43×
Q3 24
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

TENB
TENB

Subscription revenue$243.2M93%
Perpetual license and maintenance revenue$10.2M4%
Other$8.7M3%

Related Comparisons